Platelet count in heart failure patients undergoing left ventricular assist device

Abstract

Abstract Aims Left ventricular assist device (LVAD) implantation, a therapy for end‐stage heart failure, is associated with platelet (PLT) activation. This study aims to evaluate the prognostic impact of PLT count in patients with LVAD implantation. Methods and Results Data from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) registry were investigated, and patients were divided into three groups according to tertiles. The dynamic change of PLT counts and its associations with long‐term outcomes were analysed. The primary outcome was long‐term mortality. A total of 19 517 patients who received the first continuous‐flow LVAD were identified from the INTERMACS registry. The PLT count underwent a dynamic change towards normalization after LVAD implantation. Compared with intermediate, both high (hazard ratio [HR], 1.09, 95% confidence interval [CI]: 1.01 to 1.17, P = 0.033) and low (HR, 1.18, 95% CI: 1.10 to 1.27, P < 0.001) pre‐implant PLT counts were associated with an increased risk of 2 year mortality. Compared with intermediate, a high post‐implant PLT count was associated with an increased risk of 4 year mortality (HR, 1.38, 95% CI: 1.26 to 1.52, P < 0.001). Besides, both pre‐ and post‐implant PLT counts exhibit a U‐shaped association with the risk of mortality. Conclusions LVAD implantation could improve the PLT count towards normalization. Abnormal pre‐/post‐implant PLT counts were independently associated with increased risks of long‐term mortality.

Keywords

• left ventricular assist device
• long‐term outcomes
• platelet count
• risk stratification